<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17561577</article-id>
      <article-id pub-id-type="pmc">2725967</article-id>
      <article-id pub-id-type="publisher-id">06-1083</article-id>
      <article-id pub-id-type="doi">10.3201/eid1304.061083</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>VIM-2&#x2013;producing <italic>Pseudomonas putida</italic>, Buenos Aires</article-title>
        <alt-title alt-title-type="running-head">VIM-2&#x2013;producing <italic>Pseudomonas putida</italic>, Buenos Aires</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Almuzara</surname>
            <given-names>Marisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Radice</surname>
            <given-names>Marcela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de G&#xE1;rate</surname>
            <given-names>Natalia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kossman</surname>
            <given-names>Alejandra</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cuirolo</surname>
            <given-names>Arabela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santella</surname>
            <given-names>Gisela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Famiglietti</surname>
            <given-names>Angela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Gutkind</surname>
            <given-names>Gabriel</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vay</surname>
            <given-names>Varolos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Universidad de Buenos Aires, Buenos Aires, Argentina</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Gabriel Gutkind, Facultad de Famacia y Bioqu&#xED;mica, Catedra de Microbiologia, Universidad de Buenos Aires, Junin 954, Buenos Aires 1113, Argentina; email: <email xlink:href="ggutkind@ffyb.uba.ar">ggutkind@ffyb.uba.ar</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2007</year>
      </pub-date>
      <volume>13</volume>
      <issue>4</issue>
      <fpage>668</fpage>
      <lpage>669</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Carbapenem resistance</kwd>
        <kwd>Pseudomonas putida</kwd>
        <kwd>VIM-2</kwd>
        <kwd>carbapenemasaes</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> <italic>Pseudomonas putida</italic> (0.03% of isolates from the culture collection of the Argentina Association of Microbiology, <ext-link ext-link-type="uri" xlink:href="http://www.aam.org.ar">www.aam.org.ar</ext-link>) infections are mainly reported in immunocompromised patients, such as newborns, neutropenic patients, and cancer patients. They are usually susceptible to extended-spectrum cephalosporins, aminoglycosides, fluoroquinolones, and carbapenems. However, isolates have been identified that produce acquired metallo-&#x3B2;-lactamases (MBLs) and are resistant to most &#x3B2;-lactams, including carbapenems.</p>
    <p>Two multidrug-resistant <italic>P</italic>. <italic>putida</italic> isolates were obtained from clinical samples at the Sanatorio Mater Dei in Buenos Aires. One isolate was obtained in March 2005 from a urine specimen of a 76-year-old woman with a urinary tract infection who was using a urethral catheter. The second isolate was obtained in May 2005 from a tracheal aspirate of a 67-year-old man with nosocomial pneumonia.</p>
    <p>Bacteria were identified by using conventional biochemical tests and the API 20NE System (API, bioM&#xE9;rieux, Lyon, France). Susceptibility tests were performed according to standard procedures. Both isolates were resistant to imipenem and meropenem (MICs &gt;32 &#x3BC;g/mL) but were susceptible to amikacin and colistin. Susceptibility data are shown in the <xref ref-type="table" rid="T1">Table</xref>.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Antimicrobial drug susceptibility profiles of 2 <italic>bla</italic><sub>VIM-2</sub>-carrying <italic>Pseudomonas putida</italic> isolates, Argentina</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="112" span="1"/>
        <col width="62" span="1"/>
        <col width="62" span="1"/>
        <thead>
          <tr>
            <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Drug</th>
            <th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">MIC (&#x3BC;g/mL)<hr/></th>
          </tr>
          <tr>
            <th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Isolate 1</th>
            <th valign="top" align="center" scope="col" rowspan="1" colspan="1">Isolate 2</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Imipenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Meropenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ertapenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">128</td>
            <td valign="top" align="center" rowspan="1" colspan="1">128</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Piperacillin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Piperacillin-tazobactam</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftazidime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">128</td>
            <td valign="top" align="center" rowspan="1" colspan="1">128</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefepime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Aztreonam</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amikacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gentamicin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciprofloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gatifloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Levofloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Moxifloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Doxycycline</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Colistin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>Screening for MBLs was performed by using a double-disk diffusion method. Disks containing 1 &#x3BC;mol/L EDTA (metal chelator) were placed on Mueller-Hinton agar plates containing the 2 isolates. Disks containing carbapenem were placed 15 mm from disks containing EDTA. An increase in the inhibition zone of the disk containing drug near the disk containing EDTA was observed for both isolates, which suggested the presence of MBLs.</p>
    <p>PCR amplification of <italic>imp</italic> and <italic>vim</italic> genes was conducted by using primers based on conserved regions of the <italic>imp</italic> and <italic>vim</italic> genes (<italic>bla</italic>IMP-F: 5&#x2032;-GAAGGCGTTTATGTTCATACTT-3&#x2032;, <italic>bla</italic>IMP-R: 5&#x2032;-GTTTGCCTTACCATATTTGGA-3&#x2032;, <italic>bla</italic>VIMG-F: 5&#x2032;-GGTGTTTGGTCGCATATC-3&#x2032;, and <italic>bla</italic>VIMG-R 5&#x2032;-TGGGCCATTCAGCCAGATC-3&#x2032;) and heat-extracted DNA as template. Reactions were performed in a T-gradient instrument (Biometra, G&#xF6;ttingen, Germany) with the following reaction conditions: 1 cycle at 95&#xB0;C for 5 min, 52&#xB0;C for 15 min, and 72&#xB0;C for 6 min, followed by 30 cycles at 95&#xB0;C for 1 min, 52&#xB0;C for 1 min, and 72&#xB0;C for 1 min, and a final reaction at 72&#xB0;C for 20 min. Amplified fragments were sequenced on both strands by using an ABI Prism DNA 3700 (Applied Biosystems, Foster City, CA, USA), and nucleotide sequences were compared by using BLAST (National Center for Biotechnology Information, Bethesda, MD, USA, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Tools/">http://www.ncbi.nlm.nih.gov/Tools/</ext-link>). Nucleotide sequences were completely homologous to the <italic>vim-2</italic> coding gene.</p>
    <p>Two repetitive-element&#x2013;based PCR (rep-PCR) assays (ERIC-PCR and REP-PCR) with primers REP-1 (5&#x2032;-IGCGCCGICATCAGGC-3&#x2032;), REP-2 (5&#x2032;-CGTCTTATCAGGCCTAC-3&#x2032;), ERIC-1 (5&#x2032;-CACTTAGGGGTCCTCAATGTA-3&#x2032;), and ERIC-2 (5&#x2032;-AAGTAAGTGACTGGGGTGAGCG-3&#x2032;) were used to characterize isolates. PCR conditions were 94&#xB0;C for 2 min, 30 cycles at 94&#xB0;C for 30 s, 50&#xB0;C for 1 min, and 72&#xB0;C for 4 min, and a final reaction at 72&#xB0;C for 7 min. Banding patterns were visually analyzed after electrophoresis of samples. Variations in band intensity were not considered to indicate genetic differences. Banding patterns obtained by REP-PCR and ERIC-PCR assays were identical in both isolates (data not shown).</p>
    <p>Among the MBLs acquired by <italic>P</italic>. <italic>putida</italic>, IMP-1 was reported by Senda et al. in Japan in 1996 (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>) and later reported in Taiwan and Japan (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). IMP-12 was the first IMP MBL described in <italic>P</italic>. <italic>putida</italic> in Europe (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). VIM-1 in <italic>P</italic>. <italic>putida</italic> was first reported in Europe (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>), and VIM-2 in <italic>P</italic>. <italic>putida</italic> was first reported in Taiwan, Republic of Korea, Japan, and France (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). Our isolates were resistant to aztreonam (MIC 64 &#x3BC;g/mL). However, carbapenem-susceptible <italic>P</italic>. <italic>putida</italic> had low levels of susceptibility because the MIC<sub>50</sub> was only 1 dilution below the current breakpoint (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Aztreonam resistance could not be transferred by conjugation between IMP-1&#x2013;producing (aztreonam-resistant) <italic>P</italic>. <italic>putida</italic> and <italic>P</italic>. <italic>aeruginosa</italic> (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>) and is not associated with a transposon carrying blaVIM-2 (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). No evidence of extended-spectrum &#x3B2;-lactamases was detected in our isolates by classic synergy assays with clavulanate plus aztreonam, ceftazidime, or cefotaxime. VIM-6&#x2013;producing <italic>P</italic>. <italic>putida</italic> isolates from Singapore (<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>) were more resistant to aztreonam (MIC &gt;128 &#x3BC;g/mL), ceftazidime, and cefepime (MIC &gt;256 &#x3BC;g/mL).</p>
    <p>Detection of <italic>bla</italic><sub>VIM-2</sub> in <italic>Pseudomonas</italic> in South America was initially reported by the SENTRY Antimicrobial Surveillance Program (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>) and included 1 <italic>P</italic>. <italic>fluorescens</italic> isolate in Chile and 3 <italic>P</italic>. <italic>aeruginosa</italic> isolates in Venezuela. To the best of our knowledge, our report is the first of VIM-2 in <italic>P</italic>. <italic>putida</italic> in Latin America. VIM-2&#x2013;producing <italic>P</italic>. <italic>putida</italic>, which were originally restricted to East Asia and only very recently found in France, may represent an emerging pathogen or function as reservoirs for resistance because of their widespread presence in the hospital environment.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p>Suggested citation for this article: Almuzara M, Radice M, de G&#xE1;rate N, Kossman A, Cuirolo A, Santella G, et al. VIM-2&#x2013;producing <italic>Pseudomonas putida</italic>, Buenos Aires [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Apr [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/eid/content/13/4/668.htm">http://www.cdc.gov/eid/content/13/4/668.htm</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was partially supported by grants from the Secretar&#xED;a de Ciencia y T&#xE9;cnica de la Universidad de Buenos Aires (UBACyT) and the Agencia Nacional de Promoci&#xF3;n Cient&#xED;fica y Tecnol&#xF3;gica to G.G. and the UBACyT to C.V. G.G. is a member of Carrera del Investigador, Consejo Nacional de Investigaciones Cient&#xED;ficas y T&#xE9;cnicas.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Senda</surname> <given-names>K</given-names></string-name>, <string-name><surname>Arakawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ichiyama</surname> <given-names>S</given-names></string-name>, <string-name><surname>Nakashima</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ohsuka</surname> <given-names>S</given-names></string-name>, <etal/><article-title>PCR detection of metallo-&#x3B2;-lactamase gene (<italic>bla</italic> <sub>IMP</sub>) in gram-negative rods resistant to broad-spectrum &#x3B2;-lactams.</article-title><source>J Clin Microbiol</source> <year>1996</year>;<volume>34</volume>:<fpage>2909</fpage>&#x2013;<lpage>13</lpage><pub-id pub-id-type="pmid">8940421</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Yomoda</surname> <given-names>S</given-names></string-name>, <string-name><surname>Okubo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Murakami</surname> <given-names>M</given-names></string-name>, <string-name><surname>Iyobe</surname> <given-names>S</given-names></string-name> <article-title>Presence of <italic>Pseudomonas putida</italic> strains harboring plasmids bearing the metallo-&#x3B2;-lactamase gene <italic>bla</italic> <sub>IMP</sub> in a hospital in Japan.</article-title><source>J Clin Microbiol</source> <year>2003</year>;<volume>41</volume>:<fpage>4246</fpage>&#x2013;<lpage>51</lpage> <pub-id pub-id-type="doi">10.1128/JCM.41.9.4246-4251.2003</pub-id><pub-id pub-id-type="pmid">12958252</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Docquier</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Riccio</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Mugnaioli</surname> <given-names>C</given-names></string-name>, <string-name><surname>Luzzaro</surname> <given-names>F</given-names></string-name>, <string-name><surname>Endimiani</surname> <given-names>A</given-names></string-name>, <string-name><surname>Toniolo</surname> <given-names>A</given-names></string-name>, <etal/><article-title>IMP-12, a new plasmid-encoded metallo-&#x3B2;-lactamase from a <italic>Pseudomonas putida</italic> clinical isolate.</article-title><source>Antimicrob Agents Chemother</source> <year>2003</year>;<volume>47</volume>:<fpage>1522</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.1128/AAC.47.5.1522-1528.2003</pub-id><pub-id pub-id-type="pmid">12709317</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lombardi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Luzzaro</surname> <given-names>F</given-names></string-name>, <string-name><surname>Docquier</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Riccio</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Perilli</surname> <given-names>M</given-names></string-name>, <string-name><surname>Coli</surname> <given-names>A</given-names></string-name>, <etal/><article-title>Nosocomial infections caused by multidrug-resistant isolated of <italic>Pseudomonas putida</italic> producing VIM-1 metallo-&#x3B2;-lactamase.</article-title><source>J Clin Microbiol</source> <year>2002</year>;<volume>40</volume>:<fpage>4051</fpage>&#x2013;<lpage>5</lpage> <pub-id pub-id-type="doi">10.1128/JCM.40.11.4051-4055.2002</pub-id><pub-id pub-id-type="pmid">12409373</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lim</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Yum</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Yong</surname> <given-names>D</given-names></string-name>, <string-name><surname>Chong</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>JM</given-names></string-name>, <etal/><article-title><italic>bla</italic> <sub>VIM-2</sub> Cassette-containing novel integrons in metallo-&#x3B2;-lactamase- producing <italic>Pseudomonas aeruginosa</italic> and <italic>Pseudomonas putida</italic> isolated disseminated in a Korean hospital.</article-title><source>Antimicrob Agents Chemother</source> <year>2002</year>;<volume>46</volume>:<fpage>1053</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.1128/AAC.46.4.1053-1058.2002</pub-id><pub-id pub-id-type="pmid">11897589</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Poirel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cabanne</surname> <given-names>L</given-names></string-name>, <string-name><surname>Collet</surname> <given-names>L</given-names></string-name>, <string-name><surname>Nordman</surname> <given-names>P</given-names></string-name> <article-title>Class II transposon-borne structure harboring metallo-&#x3B2;-lactamase gene <italic>bla</italic><sub>VIM-2</sub> in <italic>Pseudomonas putida.</italic></article-title><source>Antimicrob Agents Chemother</source> <year>2006</year>;<volume>50</volume>:<fpage>2889</fpage>&#x2013;<lpage>91</lpage> <pub-id pub-id-type="doi">10.1128/AAC.00398-06</pub-id><pub-id pub-id-type="pmid">16870796</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vay</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Almuzara</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rodr&#xED;guez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Pugliese</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lorenzo Barba</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mattera</surname> <given-names>J</given-names></string-name>, <etal/><article-title>&#x2018;In vitro&#x2019; activity of different antimicrobial agents on gram-negative nonfermentative bacilli, excluding <italic>Pseudomonas aeruginosa</italic> and <italic>Acinetobacter</italic> spp.</article-title><comment>[in Spanish]</comment> <source>Rev Argent Microbiol</source> <year>2005</year>;<volume>37</volume>:<fpage>34</fpage>&#x2013;<lpage>45</lpage><pub-id pub-id-type="pmid">15991478</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Sader</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>RN</given-names></string-name> <article-title>Antimicrobial susceptibility of uncommonly isolated non-enteric gram-negative bacilli.</article-title><source>Int J Antimicrob Agents</source> <year>2005</year>;<volume>25</volume>:<fpage>95</fpage>&#x2013;<lpage>109</lpage> <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2004.10.002</pub-id><pub-id pub-id-type="pmid">15664479</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Koh</surname> <given-names>TH</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>GCY</given-names></string-name>, <string-name><surname>Song</surname> <given-names>LH</given-names></string-name> <article-title>IMP-1 and a novel metallo-&#x3B2;-lactamase, VIM-6, in fluorescent pseudomonads isolated in Singapore.</article-title><source>Antimicrob Agents Chemother</source> <year>2004</year>;<volume>48</volume>:<fpage>2334</fpage>&#x2013;<lpage>6</lpage> <pub-id pub-id-type="doi">10.1128/AAC.48.6.2334-2336.2004</pub-id><pub-id pub-id-type="pmid">15155248</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Mendes</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Castanheira</surname> <given-names>M</given-names></string-name>, <string-name><surname>Garcia</surname> <given-names>P</given-names></string-name>, <string-name><surname>Guzman</surname> <given-names>M</given-names></string-name>, <string-name><surname>Toleman</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Walsh</surname> <given-names>TR</given-names></string-name>, <etal/><article-title>First isolation of blaVIM-2 in Latin America: report from the SENTRY Antimicrobial Surveillance Program.</article-title><source>Antimicrob Agents Chemother</source> <year>2004</year>;<volume>48</volume>:<fpage>1433</fpage>&#x2013;<lpage>4</lpage> <pub-id pub-id-type="doi">10.1128/AAC.48.4.1433-1434.2004</pub-id><pub-id pub-id-type="pmid">15047562</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
